journal article·2011-03

Dendritic cell responses to surface properties of clinical titanium surfaces

Peng Meng Kou, Zvi Schwartz, Barbara D. Boyan, Julia E. Babensee

Acta Biomaterialia· Volume 7· Issue 3
Publisher page

Abstract

Dendritic cells (DCs) play pivotal roles in responding to foreign entities during the innate immune response and in initiating effective adaptive immunity as well as maintaining immune tolerance. The sensitivity of DCs to foreign stimuli also makes them useful cells to assess the inflammatory response to biomaterials. Elucidating material property-DC phenotype relationships using a well-defined biomaterial system is expected to provide criteria for immunomodulatory biomaterial design. Clinical titanium (Ti) substrates, including pretreatment (PT), sand blasted and acid etched (SLA), and modified SLA (modSLA), with different roughnesses and surface energies were used to treat DCs and resulted in differential DC responses. PT and SLA induced a mature DC (mDC) phenotype, while modSLA promoted a non-inflammatory environment by supporting an immature DC (iDC) phenotype, based on surface marker expression, cytokine production profiles and cell morphology. Principal component analysis (PCA) confirmed these experimental results, and also indicated that the non-stimulating property of modSLA covaried with certain surface properties, such as high surface hydrophilicity, percent oxygen and percent Ti of the substrates. In addition to previous research that demonstrated superior osteogenic properties of modSLA compared with PT and SLA, the results reported herein indicates that modSLA may further benefit implant osteointegration by reducing local inflammation and its associated osteoclastogenesis.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Immunotherapy and Immune Responses · Antimicrobial Peptides and Activities · Cell Adhesion Molecules Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (49)

Show source-provided references
1. Immunobiology of dendritic cells10.1146/annurev.immunol.18.1.767 ↗
2. Steady-state and inflammatory dendritic-cell development10.1038/nri1996 ↗
3. Innate immunity: Lipoproteins take their toll on the host10.1016/S0960-9822(00)80073-1 ↗
4. Cooperation of toll-like receptor signals in innate immune defence10.1038/nri2038 ↗
5. The danger model: A renewed sense of self10.1126/science.1071059 ↗
6. Taking dendritic cells into medicine10.1038/nature06175 ↗
7. Tolerogenic dendritic cells10.1146/annurev.immunol.21.120601.141040 ↗
8. Identification of immunostimulatory dendritic cells in the synovial effusions of patients with rheumatoid arthritis10.1172/JCI112036 ↗
9. Dendritic cells and the pathogenesis of rheumatoid arthritis10.1002/jlb.66.2.286 ↗
10. RANK and RANKL expression as markers of dendritic cell–T cell interactions in paired samples of rheumatoid synovium and lymph nodes10.1002/art.21211 ↗
11. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand10.1038/46303 ↗
12. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection10.1172/JCI10763 ↗
13. Gravallese EM. Bone destruction in arthritis. Ann Rheum Dis 2002;61(Suppl 2):ii84–86.10.1136/ard.61.suppl_2.ii84 ↗
14. The role of acquired immunity and periodontal disease progression10.1177/154411130301400402 ↗
15. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption10.1177/10454411010120020301 ↗
16. Differential levels of dendritic cell maturation on different biomaterials used in combination products10.1002/jbm.a.30429 ↗
17. Differential effects of agarose and poly(lactic–co-glycolic acid) on dendritic cell maturation10.1002/jbm.a.30798 ↗
18. The effect of the physical form of poly(lactic–co-glycolic acid) carriers on the humoral immune response to co-delivered antigen10.1016/j.biomaterials.2004.08.023 ↗
19. Norton LW, Park J, Babensee JE. Biomaterial adjuvant effect is attenuated by anti-inflammatory drug delivery or material selection. J Control Release 2010, in Press.10.1016/j.jconrel.2010.05.032 ↗
20. Requirement for both micron- and submicron scale structure for synergistic responses of osteoblasts to substrate surface energy and topography10.1016/j.biomaterials.2007.02.024 ↗
21. High surface energy enhances cell response to titanium substrate microstructure10.1002/jbm.a.30320 ↗
22. Osteoblasts generate an osteogenic microenvironment when grown on surfaces with rough microtopographies10.22203/eCM.v006a03 ↗
23. Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63)10.1002/jbm.820290314 ↗
24. Osteoblast-like cells are sensitive to submicron-scale surface structure10.1111/j.1600-0501.2005.01195.x ↗
25. Enhanced bone apposition to a chemically modified SLA titanium surface10.1177/154405910408300704 ↗
26. Bornstein · Clin Implant Dent Relat Res · 2009 · 11 · 33810.1111/j.1708-8208.2009.00148.x ↗
27. Early loading at 21 days of non-submerged titanium implants with a chemically modified sandblasted and acid-etched surface. 3-year results of a prospective study in the posterior mandible10.1902/jop.2010.090727 ↗
28. Enhancing surface free energy and hydrophilicity through chemical modification of microstructured titanium implant surfaces10.1002/jbm.a.30518 ↗
29. Osteoblast response to titanium surface roughness and 1alpha, 25-(OH)2D3 is mediated through the mitogen-activated protein kinase (MAPK) pathway10.1002/1097-4636(20010905)56:3<417::AID-JBM1111>3.0.CO;2-K ↗
30. Proliferating dendritic cell progenitors in human blood10.1084/jem.180.1.83 ↗
31. Validation of a high-throughput methodology to assess the effects of biomaterials on dendritic cell phenotype10.1016/j.actbio.2010.01.023 ↗
32. Morphological assessment of hepatoma cells (HepG2) microencapsulated in a HEMA–MMA copolymer with and without Matrigel10.1002/jbm.820261102 ↗
33. Data-driven modelling of signal-transduction networks10.1038/nrm2041 ↗
34. Collecting and organizing systematic sets of protein data10.1038/nrm2042 ↗
35. Cue–signal–response analysis of TNF-induced apoptosis by partial least squares regression of dynamic multivariate data10.1089/cmb.2004.11.544 ↗
36. Adhesive substrate-modulation of adaptive immune responses10.1016/j.biomaterials.2008.08.040 ↗
37. Profiles of carbohydrate ligands associated with adsorbed proteins on self-assembled monolayers of defined chemistries10.1002/jbm.a.32457 ↗
38. Dendritic cell responses to self-assembled monolayers of defined chemistries10.1002/jbm.a.32487 ↗
40. Monocyte chemoattractant protein-1 expression and monocyte recruitment in osseous inflammation in the mouse10.1210/endo.136.6.7750500 ↗
41. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses10.1073/pnas.0510965103 ↗
42. Interleukin-1610.1002/jlb.67.6.757 ↗
43. Involvement of IL-16 in the induction of airway hyper-responsiveness and up-regulation of IgE in a murine model of allergic asthma10.4049/jimmunol.160.6.2998 ↗
44. CD4 ligand IL-16 inhibits the mixed lymphocyte reaction10.4049/jimmunol.157.5.1958 ↗
45. IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis10.4049/jimmunol.162.7.4293 ↗
46. Poly(lactic–co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells10.1002/jbm.a.30131 ↗
47. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFκB ligand for bone resorption10.1074/jbc.M510156200 ↗
48. Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts10.1074/jbc.M611781200 ↗
49. Direct and indirect effects of microstructured titanium substrates on the induction of mesenchymal stem cell differentiation towards the osteoblast lineage10.1016/j.biomaterials.2009.12.029 ↗